Group One Trading
CNTA

Group One Trading’s Centessa Pharmaceuticals CNTA Stock Holding History

Group One Trading’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Buy
37,300
+22,900
+159% +$586K ﹤0.01% 2361
2025
Q4 		$360K Buy
14,400
+7,800
+118% +$198K ﹤0.01% 3844
2025
Q3 		$160K Hold
6,600
– – ﹤0.01% 4910
2025
Q2 		$86.7K Buy
6,600
+4,800
+267% +$60.8K ﹤0.01% 5099
2025
Q1 		$25.9K Buy
+1,800
New +$29.5K ﹤0.01% 5643
2024
Q4 		– Sell
-200
Closed -$3.2K – 7355
2024
Q3 		$3.2K Buy
+200
New +$2.45K ﹤0.01% 6025

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Group One Trading's CNTA Position: Q4 2025 in Review

Group One Trading sold out of Centessa Pharmaceuticals (CNTA) in Q4 2025, closing a stake of 2,461 shares — an estimated $62.3K sold.

Group One Trading first reported a position in CNTA in Q3 2025 and held it in 1 quarter. The position peaked at $59.7K in Q3 2025. 146 funds tracked by Wall St. Rank hold CNTA as of Q4 2025.

  • Group One Trading reported no remaining Centessa Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 2,461 Centessa Pharmaceuticals shares in Q4 2025, an estimated $62.3K.
  • Group One Trading first reported a position in Centessa Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Group One Trading's Centessa Pharmaceuticals position peaked at $59.7K in Q3 2025.
  • 146 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.